Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Clinical manifestations of COVID-19: An overview of 102 systematic reviews with evidence mapping.Journal of evidence-based medicine · 2022
   Pooled it
2. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis.BMJ open · 2020
   Pooled it
3. Comparison of Epidemiological Variations in COVID-19 Patients Inside and Outside of China-A Meta-Analysis.Frontiers in public health · 2020
   Pooled it
4. Risk classification for the transmission of vaccine-preventable diseases in the state of Minas Gerais, Brazil: 2018 to 2022.PloS one · 2024
   Article
5. Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study.Infectious diseases & immunity · 2022
   Article
6. Impact of COVID-19 pandemic on vaccination against meningococcal C infection in Brazil.Vaccine: X · 2022
   Article
7. A Faster, Novel Technique to Detect COVID-19 Neutralizing Antibodies.Medical science monitor : international medical journal of experimental and clinical research · 2022
   Article
8. Impact of COVID-19 on liver.World journal of clinical cases · 2021
   Review
9. Gender-based differences in COVID-19.New microbes and new infections · 2021
   Article
10. A Comprehensive Summary of the Knowledge on COVID-19 Treatment.Aging and disease · 2021
    Review
11. Cardiovascular disease due to novel coronavirus and the search for investigational therapies.Journal of vascular surgery · 2021
    Article
12. Approaches towards fighting the COVID‑19 pandemic (Review).International journal of molecular medicine · 2021
    Review
13. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City.PloS one · 2020
    Article
14. Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China.Frontiers in neurology · 2020
    Review
15. Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar.SN comprehensive clinical medicine · 2020
    Review
16. Drug targets for COVID-19 therapeutics: Ongoing global efforts.Journal of biosciences · 2020
    Review
17. Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes.Travel medicine and infectious disease
    Review
18. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.Travel medicine and infectious disease
    Article

Corrections and comments

• Comment on
  Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as